To CANCER IMMUNITY Home Page

Figure 2

Expression profiles of FAP-alpha in neuroectodermal, hematopoietic, and mesenchymal cancers, and in related normal tissues. (A) Whisker-box plots showing expression profiles determined by eNorthern analysis. SCC, squamous cell carcinoma; BCC, basal cell carcinoma; Mel (P), primary melanoma; Mel (M), metastatic melanoma; NHD, Non-Hodgkin’s disease; HD, Hodgkin’s disease; GBM, glioblastoma; GCT, giant cell tumor of bone; OS, osteosarcoma; CHS, chondrosarcoma; MFH, malignant fibrous histiocytoma; SpCSa, spindle cell sarcoma; LS, liposarcoma; LMS, leiomyosarcoma; SyCS, synovial cell sarcoma. Normal soft tissue consisted of normal skeletal muscle, adipose tissue from the thigh, and uterine ligament soft tissues. (B) FAP-alpha expression, as determined by immunohistochemistry with mAb F19.

 

Copyright © 2005 by Pilar Garin-Chesa